Page last updated: 2024-10-29

iohexol and Hilar Cholangiocarcinoma

iohexol has been researched along with Hilar Cholangiocarcinoma in 1 studies

Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.

Research Excerpts

ExcerptRelevanceReference
"To compare the enhancement pattern of hilar cholangiocarcinoma on contrast-enhanced ultrasound (CEUS) with that on contrast-enhanced computed tomography (CECT)."1.36Enhancement pattern of hilar cholangiocarcinoma: contrast-enhanced ultrasound versus contrast-enhanced computed tomography. ( Chen, LD; Lin, MX; Liu, GJ; Lu, MD; Wang, Z; Xie, XH; Xie, XY; Xu, HX; Xu, ZF, 2010)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Xu, HX1
Chen, LD1
Xie, XY1
Xie, XH1
Xu, ZF1
Liu, GJ1
Lin, MX1
Wang, Z1
Lu, MD1

Other Studies

1 other study available for iohexol and Hilar Cholangiocarcinoma

ArticleYear
Enhancement pattern of hilar cholangiocarcinoma: contrast-enhanced ultrasound versus contrast-enhanced computed tomography.
    European journal of radiology, 2010, Volume: 75, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Contrast

2010